Listen Now!

Business Talk 24-7

Georgia Tech Wearable Computing Center

Georgia Tech Wearable Computing Center

Maribeth Gandy Coleman

Georgia Tech Wearable Computing Center

Jay Shaffer and I sat down with Maribeth Gandy, Principal Research Scientist, and Director of Georgia Tech Wearable Computing Center.  We talked about research the university is conducting in conjunction with ShareCare to look at how wearable and mobile technology can impact stress levels for individuals using these devices.

Check back soon for more information!

Special Guest:

Maribeth Gandy Coleman, Principal Research Scientist/Director, Georgia Tech Wearable Computing Center

 

Neurgain

Neurgain

Sai Kumar

Neurgain

Chronic back pain (traumatic and neuropathic) affects over 26 million Americans, of which about 7 million have spinal stiffness (spasticity).  Current therapeutic management is not working: drugs in use have poor efficacy, and cause undesirable side effects such as resistance, dependency/abuse and other disorders.

The estimated annual economic burden of back pain is over $150 billion.  Our mission is to positively impact this “pain” by means of our patented innovation to provide a therapy that works, improves patient’s quality of life and reduces the overall burden.

Neurgain Technologies, Inc., is a Delaware Corporation founded to license, develop and commercialize the technologies arising from Dr. Martin Marsala’s regenerative medical research at the University of California-San Diego (UCSD).  The innovation is distinguished by a unique combination of a novel delivery method and a specially designed device for practicing it, both of which are patented.

The delivery method has been validated in both rodent and swine models; and we have verified the satisfactory functionality of a proof-of-concept device prototype.

Special Guest:

Sai Kumar, Principal, DiligentCXO

Neurgain

Return of the House Call

house calls

Return of the House Call

We sat down with Sam Zebarjadi of Medicast on this week’s show.  This company is using technology to facilitate the return of the house call as model of healthcare delivery.  Founded in 2013, Medicast is a healthcare technology company that enables hospitals and health systems to deliver care in a patient’s own home. Medicast’s platform, Virtual Practice, is used by organizations to send nurses and doctors to patient’s homes as an alternative to traditional primary or urgent care visits in a clinic—often in 2 hours or less from the time a visit is requested.

Medicast is a Techstars and StartUp Health company, and was recently recognized by Becker’s Hospital Review as one of the top disruptive healthcare companies to watch in 2016.

Check back soon for more information!

Halyard Health Provides Alternative To Opioid Pain Meds

opioid

Dr. Kevin Friedman of Halyard Health

Halyard Health Provides Alternative To Opioid Pain Meds

The current opioid abuse epidemic has been called the worst drug crisis in American history. Death rates now
rival those of AIDS during the 1990s, with overdoses from heroin and other opioids now killing more
than 27,000 people a year. People across the country are asking themselves: why? What are the forces
causing this issue, and what can lawmakers and the healthcare community do to curb it? At the heart of
the epidemic is the shift in opioid prescribing practices: in 1991, doctors wrote 76 million prescriptions
for painkillers.

In 2012, that number tripled, with healthcare providers writing 259 million prescriptions for opioid painkillers – enough for every American adult to have a bottle of pills.1 Most addicts aren’t introduced to opioids through the black market; they are far too often prescribed by their doctors as part of standard treatment protocols for treating postoperative and chronic pain.

On this episode we were joined in studio by Kevin Friedman, medical director at Alpharetta, Georgia-based Halyard Health.  The company manufactures two non-narcotic alternatives – COOLIEF Cooled Radiofrequency and the ON-Q* Pain Relief System – for chronic and post-operative pain, respectively.  Kevin shared actionable steps to address the opioid crisis and how patient/provider education, coupled with non-opioid therapies such as these for pain management, play a critical role in reducing the rate of occurrence of opioid addiction due to prescription use.

Halyard Health is a global medical technology company focused on preventing infection, eliminating pain and speeding
recovery.   Just as a halyard fuels forward movement, Halyard Health’s clinically-superior products and remarkable
service help to advance health and healthcare worldwide. Halyard sells its recognized brands and products in more
than 100 countries, and holds leading market positions in multiple categories across the portfolio. Formerly part of
Kimberly-Clark, Halyard became an independent company on November 1, 2014.

For more information, visit
www.halyardhealth.com.

Special Guest:

Dr. Kevin Friedman, DO, Medical Director, Halyard Health  twitter_logo_small  facebook_logo_small3  linkedin_small1

opioid

  • Doctor of Osteopathic Medicine and Surgery, Nova Southeastern University
  • MBA, IU Kelley School of Business
  • Former Flight Surgeon, US Navy